TherapeuticsMD (TXMD) EBT Margin (2011 - 2026)
TherapeuticsMD (TXMD) posted EBT Margin of 14.23% for Q1 2026, up 121.9% on a QoQ basis from 64.95% in Q4 2025, and up 18420.0% year-over-year from N/an in Q1 2025.
TherapeuticsMD (TXMD) EBT Margin (2011 - 2026) Analysis & Trends
TherapeuticsMD's EBT Margin history runs 16 years deep, the most recent figure standing at 14.23% for Q1 2026.
- Quarterly EBT Margin rose 18420.0% year-over-year to 14.23% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.52% (up 12313.0% YoY) and the FY2025 annual result came in at 21.61%, up 11144.0% from the prior year.
- EBT Margin was 14.23% for Q1 2026 at TherapeuticsMD, up from 64.95% in the prior quarter.
- Across five years, EBT Margin topped out at 70.67% in Q4 2022 and bottomed at 4273.85% in Q2 2022.
- A 5-year average of 942.04% and a median of 258.47% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin tumbled 408842 bps — and 2023, when it surged 372145 bps.
- TherapeuticsMD's EBT Margin stood at 70.67% in 2022, then plunged by 578 bps to 337.74% in 2023, then jumped by 104 bps to 12.44% in 2024, then tumbled by 622 bps to 64.95% in 2025, then jumped by 122 bps to 14.23% in 2026.
- Business Quant data shows TXMD's EBT Margin at 14.23% in Q1 2026, 64.95% in Q4 2025, and 6.38% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | 14.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.23% |
| Dec 31, 2025 | -64.95% |
| Sep 30, 2025 | 6.38% |
| Jun 30, 2025 | 57.25% |
| Mar 31, 2025 | -169.97% |
| Dec 31, 2024 | 12.44% |
| Sep 30, 2024 | -103.66% |
| Jun 30, 2024 | -448.72% |
| Mar 31, 2024 | -258.47% |
| Dec 31, 2023 | -337.74% |
| Sep 30, 2023 | -2,705.66% |
| Jun 30, 2023 | -552.40% |
| Mar 31, 2023 | -555.29% |
| Dec 31, 2022 | 70.67% |
| Sep 30, 2022 | -4,133.05% |
| Jun 30, 2022 | -4,273.85% |
| Mar 31, 2022 | -2,571.94% |
| Dec 31, 2021 | 268.50% |
| Sep 30, 2021 | -186.65% |
| Jun 30, 2021 | -185.44% |